Google
 
Google

World Stem Cell Summit 2010

Wednesday, December 24, 2008

Bone Marrow Transplantation - Table of Contents alert Volume 42 Issue 12

BONE MARROW TRANSPLANTATION

December 2008 Volume 42 Number 12, pp 773 - 839
---------------------------------------------------------------------
If you are unable to access the articles in this Table of
Contents e-alert, your library may not subscribe to
Bone Marrow Transplantation. Library recommendation through
our online recommendation form is a simple way to make
your librarian aware that this journal is valuable to your research.
Recommend now at
http://links.ealert.nature.com/ctt?kn=41&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0.

---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://links.ealert.nature.com/ctt?kn=16&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0 to start your
subscription today.

----------------------
REVIEW
----------------------
Hematopoietic SCT for peripheral T-cell lymphoma
A Gutierrez, M D Caballero, G Perez-Manga and J Rodriguez
Abstract: http://links.ealert.nature.com/ctt?kn=32&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=14&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

----------------------
ORIGINAL ARTICLES
----------------------
Outcome of second allogeneic transplants using reduced-intensity
conditioning following relapse of haematological malignancy after
an initial allogeneic transplant
B E Shaw, G J Mufti, S Mackinnon, J D Cavenagh, R M Pearce,
K E Towlson, J F Apperley, R Chakraverty, C F Craddock, M A Kazmi,
T J Littlewood, D W Milligan, A Pagliuca, K J Thomson, D I Marks and N H Russell
Abstract: http://links.ealert.nature.com/ctt?kn=3&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=23&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

Allogeneic SCT in refractory or relapsed adult ALL is effective
without prior reinduction chemotherapy
T H Terwey, G Massenkeil, I Tamm, P G Hemmati, S Neuburger,
P Martus, B Dorken, D Hoelzer and R Arnold
Abstract: http://links.ealert.nature.com/ctt?kn=15&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=49&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

Iron overload adversely affects outcome of allogeneic hematopoietic
cell transplantation
V Pullarkat, S Blanchard, B Tegtmeier, A Dagis, K Patane, J Ito and S J Forman
Abstract: http://links.ealert.nature.com/ctt?kn=63&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=38&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

GVHD after chemotherapy conditioning in allogeneic transplanted mice
B Sadeghi, N Aghdami, Z Hassan, M Forouzanfar, B Rozell,
M Abedi-Valugerdi and M Hassan
Abstract: http://links.ealert.nature.com/ctt?kn=48&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=44&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

Quality of life and social integration after allogeneic hematopoietic SCT
S Bieri, E Roosnek, C Helg, F Verholen, D Robert, B Chapuis, J Passweg,
R Miralbell and Y Chalandon
Abstract: http://links.ealert.nature.com/ctt?kn=50&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=40&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

----------------------
LETTERS TO THE EDITOR
----------------------
Long-term lymphoid-restricted split chimerism after myeloablative
allogeneic BMT for bcr-abl+ ALL
A Spyridonidis, H Bertz, M Waterhouse and J Finke
http://links.ealert.nature.com/ctt?kn=55&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

Restoration of donor chimerism by nilotinib in a chronic myeloid
leukaemia patient post mutation-associated imatinib mesylate resistance
and allogeneic stem cell transplant failure
L M O'Connor, S Langabeer, S R McCann and E Conneally
http://links.ealert.nature.com/ctt?kn=29&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

No impact of NOD2/CARD15 on outcome after SCT: a reply
N P Mayor, B E Shaw, J A Madrigal and S G E Marsh
http://links.ealert.nature.com/ctt?kn=11&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

----------------------
CORRIGENDUM
----------------------
Ovarian shielding allows ovarian recovery and normal birth in
female hematopoietic SCT recipients undergoing TBI
K Nakagawa, Y Kanda, H Yamashita, S Nakagawa, N Sasano,
K Ohtomo, K Oshima, K Kumano, N Ban, Y Nannya, M Kurokawa and S Chiba
http://links.ealert.nature.com/ctt?kn=34&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0

---------------------------------------------------------------------
Submit your research through our online submission site at
http://links.ealert.nature.com/ctt?kn=26&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0. Papers benefit
from wide readership through hosting on nature.com and inclusion in
the leading abstracting and indexing services. Rapid publication is
also assured through Advance Online Publication.

=====================================================================

You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=17&m=30775149&r=MTUwNzQwOTg3MwS2&b=2&j=NDQ0MDk5NDgS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© Copyright 2008 Nature Publishing Group

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time